Search Results
Baxter Obtains U.S. FDA Emergency Use Authorization for Regiocit Replacement Solution Used in CRRT
Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for Regiocit, the company’s replacement solution that contains citrate for regional citrate anticoagulation of the extracorporeal circuit.
Baxter Obtains U.S. FDA Emergency Use Authorizations for HF20 Set and ST Set Used in CRRT During COVID-19 Pandemic
Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received Emergency Use Authorizations (EUAs) from the U.S. Food and Drug Administration (FDA) for the company’s HF20 Set and ST Set used in continuous renal replacement therapy (CRRT).
Baxter Introduces Virtual Peritoneal Dialysis Excellence Academy For Nurses in the U.S.
Baxter International, Inc. (NYSE:BAX), a global innovator in renal care, announced today the launch of the PD Excellence Academy, a new virtual training platform and educational resource center to help nurses develop their PD skills to deliver optimal patient care. The platform also offers a benefit to employers, including dialysis clinic administrators and nephrologists, who now have an additional resource available to develop and retain talent.
Baxter Reports Second-Quarter 2020 Results
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the second quarter of 2020 and provided its outlook for full-year 2020.
Baxter and Ayogo Announce Partnership for Unique Digital Health Solutions for Home Dialysis
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, and Ayogo Health Inc., a behavioral science-based digital health company, announced the expansion of their partnership to support the needs of patients with kidney disease through digital health solutions.
Building From Within
Leader of Business Transformation Office talks career advancement at Baxter
Baxter and VIPUN Medical Announce Collaboration to Commercialize Innovative Gastric Monitoring System to Help Enhance Clinical Nutrition
Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, and VIPUN Medical, a company developing technology solutions to help improve medical nutrition, today announced an agreement to commercialize the VIPUN Gastric Monitoring System.
Empowered to Succeed
Living with disabilities fuels senior HR manager's determination to achieve
Baxter Ranks in Top 10% on Disability Equality Index
Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today it has been named a top-scoring company on the 2020 Disability Equality Index® (DEI) by Disability:IN, the leading nonprofit resource for business disability inclusion worldwide. The company's 90% score places it in the top 10% of all companies in the index and earns the "Best Place to Work for Disability Inclusion" recognition.
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.245 per share of common stock. The dividend is payable on October 1, 2020, to shareholders of record as of August 31, 2020. The indicated annual dividend rate is $0.98 per share of common stock. About Baxter